Listar por tema "Multiple sclerosis"

Ordenar por:Orden:Resultados:

  • CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis 
    Menezes, Soraya Maria; Decanine, Daniele; Brassat, David; Khouri, Ricardo; Schnitman, Saul V.; Kruschewsky, Ramon; López, Giovanni; Alvarez, Carolina; Talledo Albujar, Michael John; Gotuzzo Herencia, José Eduardo; Vandamme, Anne-Mieke; Galvão-Castro, Bernardo; Liblau, Roland; Weyenbergh, Johan Van (BioMed Central, 2014)
    Background: Human T-cell lymphotropic virus (HTLV-1) is the causative agent of the incapacitating, neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Currently, there are no ...
  • Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms 
    Moransard, M.; Bednar, M.; Frei, K.; Gassmann, M.; Ogunshola, O. O. (BioMed Central, 2017)
    BACKGROUND: Treatment with erythropoietin (Epo) in experimental autoimmune encephalomyelitis (EAE), the rodent model of multiple sclerosis (MS), has consistently been shown to ameliorate disease progression and improve ...
  • Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents 
    Finkelsztejn, A.; Gabbai, A.A.; Fragoso, Y.D.; Carrá, A.; Macías-Islas, M.A.; Arcega-Revilla, R.; García-Bonitto, J.; Oehninger-Gatti, C.L.; Orozco-Escobar, G.; Tarulla, A.; Vergara, F.; Vizcarra-Escobar, Darwin (SP Academia Brasileira de Neurologia, 2012)
    Objective: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and NorthAmerican algorithms for the treatment of multiple sclerosis do not foresee our regional ...
  • Management of relapsing-remitting multiple sclerosis in Latin America: practical recommendations for treatment optimization 
    Correale, Jorge; Abad, Patricio; Alvarenga, Regina; Alves-Leon, Soniza; Armas, Elizabeth; Barahona, Jorge; Buzo, Ricardo; Corona, Teresa; Cristiano, Edgardo; Gracia, Fernando; Bonitto, Juan Garcia; Macias, Miguel Angel; Soto, Arnoldo; Vizcarra-Escobar, Darwin; Freedman, Mark S. (Elsevier, 2014)
    The Latin American MS Experts' Forum has developed practical recommendations on the initiation and optimization of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis (RRMS). The recommendations ...
  • Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America 
    Steinberg, Judith; Fragoso, Yara D.; Duran Quiroz, Juan Carlos; Garcia, Juan Raul; Guerra, Caroline; Rodriguez, Virginia; Carcamo Rodriguez, Claudia; Ciampi, Ethel; Correa-Diaz, Edgar; Macias, Miguel; Novarro, Nelson; Vizcarra-Escobar, Darwin; Oehninger Gatti, Carlos; Orozco, Geraldine; Carra, Adriana (Springer, 2019)
    The use of biosimilar drugs for multiple sclerosis (MS) has become widespread in Latin America, with the goal of reducing costs of treatments, promoting the sustainability of healthcare systems, and improving patient ...
  • Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM 
    Rojas, Juan I.; Carnero-Contentti, Edgar; Abad, Patricio; Aguayo, Adriana; Alonso, Ricardo; Bauer, Johana; Becker, Jefferson; Bustos, Andrea K.; Carcamo, Claudia A.; Carra, Adriana; Correa-Díaz, Edgard P.; Correale, Jorge; Cristiano, Edgardo; Díaz, Alejandro J.; Fernández-Liguori, Nora; Flores, Jose; Fruns, Manuel; Garcea, Orlando; Giachello, Susana M.; Godoy, Melisa D.; Gracia, Fernando; Hamuy, Victor F.; Henestroza, Paula R.; Navarra, Javier A.; Navas, Carlos; Patrucco, Liliana; Pérez-Bruno, Magdalena; Prato, Andrea S.; Rivera, Víctor M.; Rosa-Martínez, Alma R.; Vanotti, Sandra; Vazquez, Macarena; Vizcarra-Escobar, Darwin; Ysrraelit, Maria C.; Alonso-Serena, Marina (Elsevier, 2021)
    As human and economic resources are limited, especially in Latin America (LATAM), it is important to identify research priorities to improve multiple sclerosis (MS) patients care in the region. The objective was to generate ...

Buscar en el Repositorio

Listar

Panel de Control